Novo Nordisk’s Principal Shareholder Backs Italian Life Sciences Accelerator
Novo Nordisk A/S’s largest shareholder is backing a new Italian startup accelerator as part of an initiative to support early-stage life science companies across Europe beyond Denmark’s borders.